A61P 43 - Drugs for specific purposes, not provided for in groups

Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
11/1997
11/19/1997	EP0807436A1 Muscular dystrophy progression depressant
11/19/1997	EP0807429A1 Cosmetic composition with retinol unsaturated fatty acid esters
11/19/1997	EP0807174A1 Modified ligands for receptor tyrosine kinases
11/19/1997	EP0807124A1 Flt4 receptor tyrosine kinase and its use in diagnosis and therapy
11/19/1997	EP0807122A1 Novel receptor
11/19/1997	EP0807114A1 Bridged indoles as matrix metalloprotease inhibitors
11/19/1997	EP0807111A1 Substituted heterocyclic compounds, preparation method therefor and pharmaceutical compositions containing same
11/19/1997	EP0807109A1 Substituted 1,4-piperazine-heteroaryl derivatives as 5-ht 1d? receptor agonists
11/19/1997	EP0807105A1 Pyridopyrimidones, quinolines and fused n-heretocycles as bradykinin antagonists
11/19/1997	EP0807104A2 Heterocyclic compounds possessing 5ht 2c? receptor antagonist activity
11/19/1997	EP0807086A1 Process for producing hydrotalcites and their metal oxides
11/19/1997	EP0806963A1 Carcinoma treatment
11/19/1997	EP0806962A1 Methods for the treatment of acid aspiration-induced acute lung injury
11/19/1997	EP0806960A1 Extracts of shark cartilage, process of production and uses thereof
11/19/1997	EP0806957A1 Combination therapy for hiv infection using the hiv protease inhibitor indinavir adn the reverse transcriptase inhibitor 3tc, optionally together with azt, ddi or ddc
11/19/1997	EP0806954A1 Inhibition of the degradation of connective tissue matrix protein components in mammals
11/19/1997	EP0806953A2 Agent for acting upon bone formation disturbances containing alkaline citrates, lactates and/or malates
11/19/1997	EP0806949A1 New pharmaceutical composition containing trimebutine and preparation process
11/19/1997	EP0806945A1 Therapeutic preparation for inhalation containing parathyro d hormone, pth
11/19/1997	EP0714418A4 Cosmetic melanins
11/19/1997	EP0679157B1 Novel 3,4-diaryl thiophenes and analogs thereof having use as antiinflammatory agents
11/19/1997	CN1165521A Phenyl peptides, method for preparing same, and pharmaceutical compositions containing said peptides
11/19/1997	CN1165520A Phenylsubstituted 4-azasteroid fluoroderivatives
11/19/1997	CN1165483A Compositions of ciplatin in comination with 2,2'-dithio-bis (ethanesulfonate) (dinesna)
11/19/1997	CN1165482A Pharmaceutical pyrazole compositions useful as inhibitors of protein kinases
11/19/1997	CN1165027A Chinese drugs preparation for promoting child intelligence development and preparation method of its solvable granules
11/19/1997	CN1165004A Body-building liquor
11/19/1997	CN1165000A Method of reducing tissue damage associated with ischemia
11/18/1997	US5688992 Compounds for treatment of signaling pathways in immune disfunction, cancer and diabetes
11/18/1997	US5688968 Enantioselective synthesis of 5,6-dihydro-(S)-4-(ethylamino)-(S)-6-methyl-4H-thieno 2,3-B!thiopyran-2-sulfonamide 7,7-dioxide
11/18/1997	US5688960 Substituted oximes, hydrazones and olefins useful as neurokinin antagonists
11/18/1997	US5688957 (3"-thioxacyclohex-1"-enyl)!-but-3'-ene-1'-ynyl!aryl and (3"-thioxacyclohex-1"-enyl)!-but-3'-ene-1'-ynyl!heteroaryl carboxylic acids and esters having retinoid-like biological activity
11/18/1997	US5688950 Tricyclic aminoalkylcarboxamides; novel dopamine D3 receptor subtype specific ligands
11/18/1997	US5688946 Amino acid derivatives having renin inhibiting activity
11/18/1997	US5688945 Compounds
11/18/1997	US5688943 Cholecystokinin antagonist; antiulcer agents; psychological drugs; anxiolytic agents; controlling appetite
11/18/1997	US5688938 Calcium receptor-active molecules
11/18/1997	US5688825 Sulfonyloxysuccimides
11/18/1997	US5688820 Nervous system disorders; psychological disorders
11/18/1997	US5688818 Enzyme inhibitors
11/18/1997	US5688814 4-amino-N-(4-methyl-4-piperidinyl)-2-methoxybenzamides
11/18/1997	US5688813 2-phenyl-3-aroylbenzothiophenes
11/18/1997	US5688811 Psychological disorders; nervous system disorders
11/18/1997	US5688805 Inhibitors of tumor necrosis factor-a, treatment of septic shock, antiinflammatory, antiallergen
11/18/1997	US5688799 9-Hydroxy-pyrido 1,2-a!pyrimidin-4-one ether derivatives
11/18/1997	US5688796 Heterocyclic substituted benzothiophenes, compositions, and methods
11/18/1997	US5688795 3-(4-phenylpiperazin-1-yl)propyl-amino, thio and oxy!-pyridine, pyrimidine and benzene derivatives as α1 -adrenoceptor antagonists
11/18/1997	US5688788 N-substituted azaheterocyclic carboxylic acids and esters thereof
11/18/1997	US5688781 Corticosteroids and antiinflammatory agents
11/18/1997	US5688768 Recombinant thrombin receptor and related pharmaceuticals
11/18/1997	US5688760 Polypeptides having bone resorption inhibitory activity comprising PTHrP-derived sequences
11/18/1997	US5688665 Binding to cyclin dependent kinases; controlling cell reproduction
11/18/1997	US5688507 Cardiovascular disorders such as treatment of angina, heart attack, stroke and as anticoagulants
11/18/1997	US5688499 Antagonism of endothelin actions
11/18/1997	CA2116288C Ph-triggered osmotic bursting delivery devices
11/13/1997	WO1997042329A1 Monoclonal antibody to cea, conjugates comprising said antibody, and their therapeutic use in an adept system
11/13/1997	WO1997042322A1 Glycoprotein hormone superagonists
11/13/1997	WO1997042224A1 Neurotactin and uses therefor
11/13/1997	WO1997042222A1 Methods and means for inhibition of cdk4 activity
11/13/1997	WO1997042219A1 MAMMALIAN ADDITIONAL SEX COMBS (MAMMALIAN Asx) ACTS AS A TUMOR SUPPRESSOR
11/13/1997	WO1997042218A1 MAMMALIAN SEX COMB ON MIDLEG (MAMMALIAN Scm) ACTS AS AN ONCOGENE
11/13/1997	WO1997042213A1 MAMMALIAN ADDITIONAL SEX COMBS (MAMMALIAN Asx) ACTS AS AN ONCOGENE
11/13/1997	WO1997042211A1 Mammalian sex comb on midleg (mammalian scm) acts as a tumor suppressor
11/13/1997	WO1997042187A1 Oxindole derivatives
11/13/1997	WO1997042174A1 Substituted indazole derivatives and their use as inhibitors phosphodiesterase (pde) type iv and the production of tumor necrosis factor (tnf)
11/13/1997	WO1997041884A1 Method of treatment
11/13/1997	WO1997041824A2 Antiangiogenic peptides derived from plasminogen
11/13/1997	WO1997033996A3 Human bikunin
11/13/1997	WO1997027177A3 Dihydropyridine-, pyridine-, benzopyran-4-one- and triazoloquinazoline derivatives, their preparation and their use as adenosine receptor antagonists
11/13/1997	CA2253971A1 Use of high dose interferon by oralmucosal contact to treat viral infections and neoplastic conditions
11/13/1997	CA2253864A1 Neurotactin and uses therefor
11/13/1997	CA2253441A1 Glycoprotein hormone superagonists
11/13/1997	CA2250579A1 Monoclonal antibody to cea, conjugates comprising said antibody, and their therapeutic use in an adept system
11/13/1997	CA2205121A1 Antiadhesive properties of polyacrylic acids and polymethacrylic acids
11/13/1997	CA2204704A1 Cosmetic composition with long chain unsaturated retinol fatty acid esters
11/12/1997	EP0806465A1 Antioxidant composition and method for production thereof
11/12/1997	EP0806432A1 Glutathione monoester sulfonate
11/12/1997	EP0806423A1 Aminomethylene substituted non-aromatic heterocycles and use as substance p antagonists
11/12/1997	EP0806419A1 Benzoxazole derivatives as serotonin 5-HT3 receptor partial activator
11/12/1997	EP0805859A1 A chemokine receptor able to bind to mcp-1, mip-1 alpha and/or rantes. its uses
11/12/1997	EP0805853A1 Lineage-directed induction of human mesenchymal stem cell differentiation
11/12/1997	EP0805820A1 Ligands for eph-like receptors
11/12/1997	EP0805816A1 Compounds with growth hormone releasing properties
11/12/1997	EP0805809A2 Aza and aza (n-oxy) analogs of glycine/nmda receptor antagonists
11/12/1997	EP0805802A1 Substituted phenyl compounds as endothelin antagonists
11/12/1997	EP0805796A1 Cell adhesion inhibitors
11/12/1997	EP0805688A1 Use of il-4 for potentiation of chemotherapeutic agents
11/12/1997	EP0805687A1 Recombinant human alpha-fetoprotein and uses thereof
11/12/1997	EP0805680A2 Combinational drugs for treating migraine and other illnesses, comprising sesquiterpene lactones and b-complex vitamins
11/12/1997	EP0730465A4 Use of angiotensin iii and analogs thereof in tissue repair
11/12/1997	EP0690850B1 2-substituted morpholine and thiomorpholine derivatives as gaba-b antagonists
11/12/1997	EP0659080A4 Method and composition for the treatment of hair loss.
11/12/1997	CN1164856A Novel alkylamino derivatives as sigma 2 selective ligands
11/12/1997	CN1164537A New pseudopeptides derived from neurokinins, process for preparing them and pharmaceutical compositions contianing them
11/12/1997	CN1164421A Preparation of drug for curing chronic fibrosis hepatic disease and acute hepatic disease using bradyknin-antagonist
11/12/1997	CN1164387A Stable carotenoid emulsions suitable for parenteral administration
11/12/1997	CN1036393C 7-(2-aminoethyl)-benzothiazolones
11/12/1997	CN1036392C Method for preparation of ring-substituted 2-amino-tetralin and 3-aminochromanes
11/12/1997	CN1036389C Phenylacetyl deriv. of 4-amino-2,6-dimethyl phenylsulfonyl-nitro-methane or preparing process thereof
11/11/1997	US5686597 Thrombin receptor homolog

1 ... 1312 1313 1314 1315 1316 1317 1318 1319 1320 1321 1322 1323 1324 1325 1326 1327 1328 1329 1330 1331 1332 ... 1564